Structure-based identification of potent VEGFR-2 inhibitors from in vivo metabolites of a herbal ingredient

被引:0
|
作者
Raju Dash
Md. Junaid
Sarmistha Mitra
Md Arifuzzaman
S. M. Zahid Hosen
机构
[1] Molecular Modeling and Drug Design Laboratory,Department of Anatomy
[2] Pharmacology Research Division,Department of Biochemistry and Biotechnology
[3] Bangladesh Council of Scientific and Industrial Research (BCSIR),Plasma Bioscience Research Center, Plasma
[4] Dongguk University Graduate School of Medicine,bio display
[5] University of Science and Technology Chittagong,Department of Natural Sciences, LAGCC
[6] Kwangwoon University,undefined
[7] City University of New York (CUNY),undefined
来源
关键词
VEGFR-2; Angiogenesis; Molecular docking; Molecular dynamics; MM-PBSA;
D O I
暂无
中图分类号
学科分类号
摘要
Vascular endothelial growth factor receptor-2 (VEGFR-2) is one of the regulatory elements of angiogenesis that is expressed highly in various diseases and is also essential for solid tumor growth. The present study was aimed at identifying potent inhibitors of VEGFR-2 by considering herbal secondary metabolites; as natural molecules are less toxic than synthetic derivatives. A structure-based virtual screening protocol consisting of molecular docking, MM-GBSA and ADME/T analysis was initially used to screen a library of in vivo metabolites of the herbal ingredient. Using a fixed cutoff value, four potent virtual hits were identified from molecular docking, ADME/T and binding affinity calculations, which were considered further for molecular dynamics (MD) simulation to broadly describe the binding mechanisms to VEGFR-2. The results suggested that these molecules have high affinity for the catalytic region of VEGFR-2, and form strong hydrophobic and polar interactions with the amino acids involved in the binding site of ATP and linker regions of the catalytic site. Subsequently, the stability of the docked complexes and binding mechanisms were evaluated by MD simulations, and the energy of binding was calculated through MM-PBSA analysis. The results uncovered two virtual hits, designated ZINC14762520 and ZINC36470466, as VEGFR-2 inhibitors, and suggested that they bind to kinase domain in an ATP-competitive manner. These virtual hits will offer a suitable starting point for the further design of their various analogs, allowing a rational search for more effective inhibitors in the future.
引用
收藏
相关论文
共 50 条
  • [1] Structure-based identification of potent VEGFR-2 inhibitors from in vivo metabolites of a herbal ingredient
    Dash, Raju
    Junaid, Md.
    Mitra, Sarmistha
    Arifuzzaman, Md
    Hosen, S. M. Zahid
    JOURNAL OF MOLECULAR MODELING, 2019, 25 (04)
  • [2] Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2
    Duncton, Matthew A. J.
    Chekler, Eugene L. Piatnitski
    Katoch-Rouse, Reeti
    Sherman, Dan
    Wong, Wai C.
    Smith, Leon M., II
    Kawakami, Joel K.
    Kiselyov, Alexander S.
    Milligan, Daniel L.
    Balagtas, Chris
    Hadari, Yaron R.
    Wang, Ying
    Patel, Sheetal N.
    Rolster, Robin L.
    Tonra, James R.
    Surguladze, David
    Mitelman, Stan
    Kussie, Paul
    Bohlen, Peter
    Doody, Jacqueline F.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (02) : 731 - 740
  • [3] Discovery of anilinopyrimidine-based naphthamide derivatives as potent VEGFR-2 inhibitors
    Lv, Yongcong
    Li, Mengyuan
    Cao, Sufen
    Tong, Linjiang
    Peng, Ting
    Wei, Lixin
    Xie, Hua
    Ding, Jian
    Duan, Wenhu
    MEDCHEMCOMM, 2015, 6 (07) : 1375 - 1380
  • [4] Design and synthesis of novel pyridazinoquinazoline derivatives as potent VEGFR-2 inhibitors: In vitro and in vivo study
    El-Gazzar, Marwa G.
    El-Hazek, Rania M.
    Zaher, Nashwa H.
    El-Ghazaly, Mona A.
    BIOORGANIC CHEMISTRY, 2019, 92
  • [5] Synthesis and structure-activity relationships of boswellic acid derivatives as potent VEGFR-2 inhibitors
    Shen, Sida
    Xu, Xingyu
    Liu, Zhulong
    Liu, Junhua
    Hu, Lihong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (09) : 1982 - 1993
  • [6] Structure-Based Virtual Screening for the Identification of High Affinity Compounds as Potent VEGFR2 Inhibitors for the Treatment of Renal Cell Carcinoma
    Sharma, Khushboo
    Patidar, Khushboo
    Ali, Meer Asif
    Patil, Pravin
    Goud, Himshikha
    Hussain, Tajamul
    Nayarisseri, Anuraj
    Singh, Sanjeev Kumar
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (25) : 2174 - 2185
  • [7] Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors
    Lv, Yongcong
    Li, Mengyuan
    Liu, Ting
    Tong, Linjiang
    Peng, Ting
    Wei, Lixin
    Ding, Jian
    Xie, Hua
    Duan, Wenhu
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (05): : 592 - 597
  • [8] Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy
    Chekler, Eugene L. Piatnitski
    Kiselyov, Alexander S.
    Ouyang, Xiaohu
    Chen, Xiaoling
    Pattaropong, Vatee
    Wang, Ying
    Tuma, M. Carolina
    Doody, Jacqueline F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (09): : 488 - 492
  • [9] Probing structural requirements for thiazole-based mimetics of sunitinib as potent VEGFR-2 inhibitors
    Abd Elhameed, Alaa A.
    Ali, Ahmed R.
    Ghabbour, Hazem A.
    Bayomi, Said M.
    El-Gohary, Nadia S.
    RSC MEDICINAL CHEMISTRY, 2025, 16 (03): : 1329 - 1349
  • [10] Evaluation of indazole-based compounds as a new class of potent KDR/VEGFR-2 inhibitors
    Bauer, David
    Whittington, Douglas A.
    Coxon, Angela
    Bready, James
    Harriman, Shawn P.
    Patel, Vinod F.
    Polverino, Anthony
    Harmange, Jean-Christophe
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) : 4844 - 4848